Delivery Order SPE2DB20D2104-SPE2DB25FMSDB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $54,189.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on October 8, 2025, with completion scheduled for October 30, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical procurement fulfilling military healthcare supply requirements...
- The Defense Logistics Agency awarded a delivery order valued at $28,553.91 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 15, 2025, with completion expected by January 7, 2026. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95 and an ultimate completion date of August 8, 2025. This is a non-set-aside, competitively awarded delivery order utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Voranigo 40 mg tablets (30-count units). This firm fixed-price contract, designated as a non-competitive, non-set-aside award, is scheduled for completion by November 28, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a $52,462.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Voranigo 40 mg tablets (30-count units) on November 24, 2025, with completion scheduled for December 16, 2025. This is a non-set-aside, competitively awarded contract with performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order as a child...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $28,553.91 on December 18, 2025, for the supply of Voranigo 40 mg tablets (30-count packages). This is a firm fixed-price delivery order with an ultimate completion date of January 12, 2026, and represents a non-set-aside, competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $26,231.49 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract. The award was issued on November 12, 2025, with an ultimate completion date of December 4, 2025, and utilizes no set-aside designation, indicating competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSDBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on May 30, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement action reflecting the contractor's capability to fulfill federal pharmaceutical supply requirements for military and defense healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC enables the company to provide flexible pharmaceutical sourcing across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.1k | 5/30/25 |